Genotype | Dosage of D. mel. Hmr^{+ a} | Dosage of other X_{me1} genes ^{a} | Viability ^{b} | References |
---|---|---|---|---|
X_{me1}, Hmr^{−}/X_{sim} females | 0 | 1 | High | Tables 3, 4 and 5 |
X_{me1}, In(1)AB/X_{sim} females | <0.5 | 1 | Tables 3, 4 and 5 | |
X_{me1}/X_{sim} ; +/Lhr females | 1 | 1 | Tables 1, 7 | |
X_{sim} males | 0 | 0 | Sturtevant (1920); Tables 6, 8 | |
X_{me1}, Hmr^{1}/X_{sim} females | ≥0.5 | 1 | High, <29° | Tables 2, 3, 5 |
X_{me1}; +/Lhr males | 2 | 2 | Intermediate^{c} | Watanabe (1979); Tables 1, 7 |
X_{me1}, In(1)AB males | <1 | 2 | Hutter et al. (1990); Table 3 | |
X_{sim}; Dp Hmr^{+} males | 2 | 0 | Tables 8, 10 | |
X_{me1}/X_{sim} females | 1 | 1 | Sturtevant (1929), Kerkis (1933b), Watanabe et al. (1977), Lee (1978); Table 1 | |
X_{me1}/X_{sim}; Dp Hmr^{+} females | 2 | 1 | Low^{c} | Table 7 |
X_{me1}, Hmr^{−}/X_{me1} females | 1 | 2 | Table 6 | |
X_{me1}, In(1)AB/X_{me1} females | <1.5 | 2 | Hutter et al. (1990); Table 6 | |
X_{me1}, Hmr^{1} males | ≥1 | 2 | Hutter and Ashburner (1987); Tables 2, 3 | |
X_{me1}, Hmr^{1}/X_{me1}, Hmr^{+} females | ≥1.5 | 2 | Lethal | Hutter et al. (1990); see also Dominant rescue of exceptional female hybrids in results. |
X_{me1}/X_{me1}, females | 2 | 2 | Sturtevant (1920) | |
X_{me1} males | 2 | 2 | Sturtevant (1920) |
↵^{a} Dosage calculations assume that X-linked genes are fully dosage compensated in hybrid males. See Hmr^{1} retains ≥50% of the activity of Hmr^{+} in discussion for the estimation of Hmr^{+} dosage for the Hmr^{1} and In(1)AB rescue alleles.
↵^{b} The order of genotypes listed within each viability class is not significant.
↵^{c} Viabilities of genotypes in these classes were often highly variable. See references for details.